However, a prespecified subgroup analysis of patients with high bronchodilator reversibility (post-bronchodilator FEV1 improvement ≥20%) demonstrated a nominally significant improvement in ACQ score.
← all excerpts
Inflammation in Asthma: Mechanistic Insights and the Role of Biologics in Therapeutic Frontiers.
2
—
—
The sentences
In LAVOLTA II, reductions were observed but did not reach statistical significance.